Eam Investors, LLC Cytokinetics Inc Transaction History

Eam Investors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $419,475 - $711,034	-6,580 Reduced 13.94%	40,625 $2.85 Million
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $1.27 Million - $3.94 Million	47,205 New	47,205 $3.94 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $248,852 - $352,035	6,457 Added 9.12%	77,259 $3.74 Million
Q2 2022 Aug 12, 2022	BUY	$33.93 - $48.92 $154,279 - $222,439	4,547 Added 6.86%	70,802 $2.78 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $1.24 Million - $1.92 Million	-41,743 Reduced 38.65%	66,255 $2.44 Million
Q4 2021 Feb 11, 2022	SELL	$34.35 - $46.38 $88,485 - $119,474	-2,576 Reduced 2.33%	107,998 $4.92 Million
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $2.05 Million - $3.95 Million	110,574 New	110,574 $3.95 Million
Q4 2020 Feb 11, 2021	SELL	$15.26 - $28.61 $482,933 - $905,420	-31,647 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$20.58 - $28.96 $1.92 Million - $2.71 Million	-93,531 Reduced 74.72%	31,647 $685,000
Q2 2020 Aug 13, 2020	BUY	$11.15 - $24.64 $1.4 Million - $3.08 Million	125,178 New	125,178 $2.95 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.77B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.